数字农科院2.0

Cd(II)-binding transcriptional regulator interacts with isoniazid and regulates drug susceptibility in mycobacteria

文献类型： 外文期刊

作者： Min Yang;Shi-Hua Jia;Hui-Ling Tao;Chen Zhu;Wan-Zhong Jia;Li-Hua Hu;Chun-Hui Gao

作者机构：

关键词： arsC; cdiR; ArsR; drug susceptibility; transcriptional regulator

期刊名称： J Biochem

ISSN： 0021-924X

年卷期： 2021 年 169 卷 1 期

页码：

收录情况： JCR（2021版）

摘要： It is urgent to understand the regulatory mechanism of drug resistance in widespread bacterial pathogens. In Mycobacterium tuberculosis, several transcriptional regulators have been found to play essential roles in regulating its drug resistance. In this study, we found that an ArsR family transcription regulator encoded by Rv2642 (CdiR) responds to isoniazid (INH), a widely used anti-tuberculosis (TB) drug. CdiR negatively regulates self and adjacent genes, including arsC (arsenic-transport integral membrane protein ArsC). CdiR directly interacts with INH and Cd(II). The binding of INH and Cd(II) both reduce its DNA-binding activity. Disrupting cdiR increased the drug susceptibility to INH, whereas overexpressing cdiR decreased the susceptibility. Strikingly, overexpressing arsC increased the drug susceptibility as well as cdiR. Additionally, both changes in cdiR and arsC expression caused sensitivity to other drugs such as rifamycin and ethambutol, where the minimal inhibitory concentrations in the cdiR deletion strain were equal to those of the arsC-overexpressing strain, suggesting that the function of CdiR in regulating drug resistance primarily depends on arsC. Furthermore, we found that Cd(II) enhances bacterial resistance to INH in a CdiR-dependent manner. As a conclusion, CdiR has a critical role in directing the interplay between Cd(II) metal ions and drug susceptibility in mycobacteria. © The Author(s) 2020. Published by Oxford University Press on behalf of the Japanese Biochemical Society. All rights reserved.

分类号：

  • 相关文献

[1]固氮斯氏假单胞菌A1501的PST1305(arsC)基因遗传进化及表达调控的研究. 樊慧俐,窦岳坦,燕永亮,平淑珍,林敏. 2008

作者其他论文 更多>>